1. Home
  2. PDLB vs LUNG Comparison

PDLB vs LUNG Comparison

Compare PDLB & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDLB
  • LUNG
  • Stock Information
  • Founded
  • PDLB 1960
  • LUNG 1995
  • Country
  • PDLB United States
  • LUNG United States
  • Employees
  • PDLB N/A
  • LUNG N/A
  • Industry
  • PDLB
  • LUNG Industrial Specialties
  • Sector
  • PDLB
  • LUNG Health Care
  • Exchange
  • PDLB Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • PDLB 285.3M
  • LUNG 299.3M
  • IPO Year
  • PDLB 2017
  • LUNG 2020
  • Fundamental
  • Price
  • PDLB $12.80
  • LUNG $7.77
  • Analyst Decision
  • PDLB
  • LUNG Strong Buy
  • Analyst Count
  • PDLB 0
  • LUNG 7
  • Target Price
  • PDLB N/A
  • LUNG $12.64
  • AVG Volume (30 Days)
  • PDLB 45.7K
  • LUNG 464.2K
  • Earning Date
  • PDLB 04-29-2025
  • LUNG 04-30-2025
  • Dividend Yield
  • PDLB N/A
  • LUNG N/A
  • EPS Growth
  • PDLB 212.14
  • LUNG N/A
  • EPS
  • PDLB 0.46
  • LUNG N/A
  • Revenue
  • PDLB $82,359,000.00
  • LUNG $83,789,000.00
  • Revenue This Year
  • PDLB $10.97
  • LUNG $17.96
  • Revenue Next Year
  • PDLB $8.59
  • LUNG $18.35
  • P/E Ratio
  • PDLB $27.72
  • LUNG N/A
  • Revenue Growth
  • PDLB 16.30
  • LUNG 22.01
  • 52 Week Low
  • PDLB $7.89
  • LUNG $5.46
  • 52 Week High
  • PDLB $13.97
  • LUNG $10.01
  • Technical
  • Relative Strength Index (RSI)
  • PDLB 45.82
  • LUNG 52.56
  • Support Level
  • PDLB $12.53
  • LUNG $7.65
  • Resistance Level
  • PDLB $13.07
  • LUNG $8.12
  • Average True Range (ATR)
  • PDLB 0.24
  • LUNG 0.49
  • MACD
  • PDLB 0.02
  • LUNG -0.06
  • Stochastic Oscillator
  • PDLB 37.97
  • LUNG 45.71

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: